SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001214659-23-013231
Filing Date
2023-10-06
Accepted
2023-10-06 16:06:43
Documents
19

Document Format Files

Seq Description Document Type Size
1 z104231f1.htm   iXBRL F-1 1130401
2 EXHIBIT 23.1 ex23_1.htm EX-23.1 6645
3 EXHIBIT 107 ex107.htm EX-FILING FEES 28548
8 GRAPHIC biodexa_logo.jpg GRAPHIC 13595
9 GRAPHIC mazars_logomed.jpg GRAPHIC 10264
10 GRAPHIC pipeline_1.jpg GRAPHIC 126545
11 GRAPHIC pipeline_2.jpg GRAPHIC 122860
  Complete submission text file 0001214659-23-013231.txt   2243908

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bdrx-20231006.xsd EX-101.SCH 2924
5 XBRL DEFINITION FILE bdrx-20231006_def.xml EX-101.DEF 26578
6 XBRL LABEL FILE bdrx-20231006_lab.xml EX-101.LAB 36491
7 XBRL PRESENTATION FILE bdrx-20231006_pre.xml EX-101.PRE 25233
13 EXTRACTED XBRL INSTANCE DOCUMENT z104231f1_htm.xml XML 4019
Mailing Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ
Business Address 1 CASPIAN POINT CASPIAN WAY CARDIFF X0 CF10 4DQ 44 (0)1235 888300
Biodexa Pharmaceuticals Plc (Filer) CIK: 0001643918 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-274895 | Film No.: 231314285
SIC: 2834 Pharmaceutical Preparations